Does face yoga actually work? Experts weigh in on its slimming, anti-aging effects
Face yoga involves a series of poses and stretches, as well as massage of the face. Oscar Gutierrez Zozulia/iStockphoto/Getty Images via CNN Newsource
Puckering, puffing, scrunching and stretching your face may look silly, but in some spaces, it's the serious business of face yoga.
The trendy facial workout involves a series of exaggerated poses and repetitive movements meant to target the muscles in the face, trading full-bodied yoga moves such as 'downward dog' for the lip-pouting 'duckface' and other expressions.
Popular for being both cost-effective and product-free, face yoga testimonies can be found all over social media, with some influencers and self-proclaimed gurus promising a 'natural facelift' effect capable of toning, slimming and reducing fine lines on the face.
But how much are these promised benefits a stretch of the truth? And how much is backed by science?
Here's what a yoga instructor, a dermatologist and the author of one of the few face yoga studies out there have to say.
The science behind face yoga
The face is made up of layers of skin, fat and muscle sitting on top of the skull.
Underneath the top layer of skin, or dermis, there is a layer of subcutaneous fat pads, which sit on top of the muscles, explained Dr. Anetta Reszko, a New York-based dermatologist and clinical assistant professor of dermatology at Weill Cornell Medical College. These muscles help us smile, frown, chew and make other facial expressions.
'The fat and the muscles work together to give the face volume,' Reszko said. 'But over time, as we age, or if we don't use those muscles because of Botox, they can atrophy (and) become smaller.'
This atrophy can cause the fat pads on top of the muscles to fall, giving the face a more sagging or hollow appearance, Reszko said.
'The idea behind facial yoga is you're working below that level, growing the muscle layer below the fat,' said Dr. Murad Alam, the vice chair of the department of dermatology and professor at Northwestern University's Feinberg School of Medicine in Chicago. 'As you grow the muscle, that would restore some shape to the face.'
Alam, who is also a practicing dermatologist, conducted one of the few known studies to test this face yoga hypothesis in 2018 on a small cohort of middle-aged adults.
After 20 weeks of daily, 30-minute exercises, a panel of dermatologists observed improved facial fullness among the 16 participants who completed the program, the study reported.
'The place where we noticed the biggest change was the cheeks,' Alam said. 'Which makes sense, because the cheek muscles are among the biggest facial muscles, so if you exercise them, the growth of them is going to be the most noticeable.'
Due to the limited sample size and lack of direct measurements, further clinical trials would be needed to affirm this volumizing effect, Alam noted. Generally, medical research without a drug or device is difficult to fund, he said.
'Is this a replacement for cosmetic procedures? Not really, because the amount of improvement was not as significant and (other cosmetic) aspects of aging weren't studied,' Alam said. 'But it's potentially useful to people who absolutely do not want any cosmetic procedures because they're concerned about the safety or the cost or the inconvenience.'
What else could face yoga do?
In Reszko's dermatology practice, she recommends face yoga exercises for increasing blood and lymphatic fluid circulation in the face.
Our faces have hundreds of lymph nodes that use fluid to drain waste and fight infection, Reszko said. During sleep, lymphatic fluid can accumulate in the face from lying down, causing a 'puffy' appearance immediately upon waking.
Moving, stretching and massaging the face for 10 to 15 minutes every day could help reduce puffiness, Reszko said, referencing other techniques such the traditional Chinese gua sha stones that are meant to serve a similar purpose. This drainage can be especially helpful for patients who recently underwent cosmetic surgery or those with chronic allergies, she said.
Increasing blood flow to the face may also make the skin appear more flushed and hydrated as well, Reszko said, but this effect is usually temporary.
If you tend to hold tension in your neck, shoulders, jaw, forehead or anywhere else on the face, face yoga also could be helpful to relax the muscles, said Annelise Hagen, a yoga instructor and self-proclaimed pioneer of the technique who authored the book 'The Yoga Face.'
'Tension is a huge enemy for a lot of us. We are making these faces without realizing it all the time.' Hagen said. 'A lot of the work I do is just trying to teach people how to notice and be more mindful, relax and take a breath.'
For Hagen, face yoga is more than just a workout or a cosmetic bio-hack — it's a way to be more in tune with your face.
In her classes, she may encourage people to lift the corners of their mouth for a neutral, 'smiling Buddha face.' Or for the neck and jaw, she'll do the 'lion's breath,' opening her mouth wide, sticking out her tongue, rolling back her eyes and exhaling.
'When you're approaching the face from a yogic perspective, it's about being mindful of what we do with the face and acknowledging that it's kind of a manifestation of something inside,' Hagen said. 'Some people may approach it differently, but anything that can make you feel more serene, calm and better about the face that you're in, I think is legitimate.'
Can face yoga be harmful?
Generally, face yoga exercises are harmless, Alam said. To cause wrinkling, frown lines, bruising or other trauma to the face, a person would have to apply painful force.
On the other hand, if someone is serious about taking up a daily face yoga routine, Reszko suggests avoiding movements that rub or stretch the delicate under-eye area. The skin around the eyes tends to be thinner and more sensitive than the rest of the face.
For more dramatic interventions like firming wrinkles or treating acne, she recommends seeking the advice of a board-certified dermatologist.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
7 hours ago
- CTV News
Does face yoga actually work? Experts weigh in on its slimming, anti-aging effects
Face yoga involves a series of poses and stretches, as well as massage of the face. Oscar Gutierrez Zozulia/iStockphoto/Getty Images via CNN Newsource Puckering, puffing, scrunching and stretching your face may look silly, but in some spaces, it's the serious business of face yoga. The trendy facial workout involves a series of exaggerated poses and repetitive movements meant to target the muscles in the face, trading full-bodied yoga moves such as 'downward dog' for the lip-pouting 'duckface' and other expressions. Popular for being both cost-effective and product-free, face yoga testimonies can be found all over social media, with some influencers and self-proclaimed gurus promising a 'natural facelift' effect capable of toning, slimming and reducing fine lines on the face. But how much are these promised benefits a stretch of the truth? And how much is backed by science? Here's what a yoga instructor, a dermatologist and the author of one of the few face yoga studies out there have to say. The science behind face yoga The face is made up of layers of skin, fat and muscle sitting on top of the skull. Underneath the top layer of skin, or dermis, there is a layer of subcutaneous fat pads, which sit on top of the muscles, explained Dr. Anetta Reszko, a New York-based dermatologist and clinical assistant professor of dermatology at Weill Cornell Medical College. These muscles help us smile, frown, chew and make other facial expressions. 'The fat and the muscles work together to give the face volume,' Reszko said. 'But over time, as we age, or if we don't use those muscles because of Botox, they can atrophy (and) become smaller.' This atrophy can cause the fat pads on top of the muscles to fall, giving the face a more sagging or hollow appearance, Reszko said. 'The idea behind facial yoga is you're working below that level, growing the muscle layer below the fat,' said Dr. Murad Alam, the vice chair of the department of dermatology and professor at Northwestern University's Feinberg School of Medicine in Chicago. 'As you grow the muscle, that would restore some shape to the face.' Alam, who is also a practicing dermatologist, conducted one of the few known studies to test this face yoga hypothesis in 2018 on a small cohort of middle-aged adults. After 20 weeks of daily, 30-minute exercises, a panel of dermatologists observed improved facial fullness among the 16 participants who completed the program, the study reported. 'The place where we noticed the biggest change was the cheeks,' Alam said. 'Which makes sense, because the cheek muscles are among the biggest facial muscles, so if you exercise them, the growth of them is going to be the most noticeable.' Due to the limited sample size and lack of direct measurements, further clinical trials would be needed to affirm this volumizing effect, Alam noted. Generally, medical research without a drug or device is difficult to fund, he said. 'Is this a replacement for cosmetic procedures? Not really, because the amount of improvement was not as significant and (other cosmetic) aspects of aging weren't studied,' Alam said. 'But it's potentially useful to people who absolutely do not want any cosmetic procedures because they're concerned about the safety or the cost or the inconvenience.' What else could face yoga do? In Reszko's dermatology practice, she recommends face yoga exercises for increasing blood and lymphatic fluid circulation in the face. Our faces have hundreds of lymph nodes that use fluid to drain waste and fight infection, Reszko said. During sleep, lymphatic fluid can accumulate in the face from lying down, causing a 'puffy' appearance immediately upon waking. Moving, stretching and massaging the face for 10 to 15 minutes every day could help reduce puffiness, Reszko said, referencing other techniques such the traditional Chinese gua sha stones that are meant to serve a similar purpose. This drainage can be especially helpful for patients who recently underwent cosmetic surgery or those with chronic allergies, she said. Increasing blood flow to the face may also make the skin appear more flushed and hydrated as well, Reszko said, but this effect is usually temporary. If you tend to hold tension in your neck, shoulders, jaw, forehead or anywhere else on the face, face yoga also could be helpful to relax the muscles, said Annelise Hagen, a yoga instructor and self-proclaimed pioneer of the technique who authored the book 'The Yoga Face.' 'Tension is a huge enemy for a lot of us. We are making these faces without realizing it all the time.' Hagen said. 'A lot of the work I do is just trying to teach people how to notice and be more mindful, relax and take a breath.' For Hagen, face yoga is more than just a workout or a cosmetic bio-hack — it's a way to be more in tune with your face. In her classes, she may encourage people to lift the corners of their mouth for a neutral, 'smiling Buddha face.' Or for the neck and jaw, she'll do the 'lion's breath,' opening her mouth wide, sticking out her tongue, rolling back her eyes and exhaling. 'When you're approaching the face from a yogic perspective, it's about being mindful of what we do with the face and acknowledging that it's kind of a manifestation of something inside,' Hagen said. 'Some people may approach it differently, but anything that can make you feel more serene, calm and better about the face that you're in, I think is legitimate.' Can face yoga be harmful? Generally, face yoga exercises are harmless, Alam said. To cause wrinkling, frown lines, bruising or other trauma to the face, a person would have to apply painful force. On the other hand, if someone is serious about taking up a daily face yoga routine, Reszko suggests avoiding movements that rub or stretch the delicate under-eye area. The skin around the eyes tends to be thinner and more sensitive than the rest of the face. For more dramatic interventions like firming wrinkles or treating acne, she recommends seeking the advice of a board-certified dermatologist.
CTV News
13 hours ago
- CTV News
You probably don't need foods with added protein, nutritionists say
A Thai peanut, vegetable and tofu bowl is displayed for a photograph in Coronado, Calif., on April 29, 2017. (Melissa d'Arabian via AP, File) The human body needs protein. Proteins carry out countless functions inside cells and they are vital for the growth, repair and maintenance of muscles, bones and skin. And with food companies rolling out high-protein versions of a huge range of foods, including milkshakes and granola bars — and even pancakes and popcorn — you might be tempted to think you need to add more to your diet. But nutritionists say that if you are getting enough food, you are probably getting enough protein. 'Adding protein to foods is very beneficial — for the profits of that food,' said Federica Amati, nutrition lead at Imperial College London and head nutritionist at the health science company ZOE. 'It is not based on health, it is not backed by science.' The amount of protein you need depends on your age, weight and personal nutritional needs and it is especially important for children and older adults to make sure they eat protein-rich foods. Here's what to know about how much protein you need and how to ensure you're getting it from the best sources. Protein is so critical that your body knows how to make it Protein is a macronutrient, or a basic kind of food like fat or carbohydrates that your body needs to function. There are thousands of proteins, assembled from smaller molecules called amino acids — most of which can be made by the body. 'Because protein is so important, our body has adapted really well to making sure that it can reassemble and change the building blocks of these amino acids to make sure we have what we need, as long as we're eating adequate amounts of food,' Amati said. Still, the body can't make all the amino acids, so some must come from food. If you aren't starving, you are probably getting plenty of protein The World Health Organization recommends that healthy adults get about 0.4 grams of protein per pound of body weight (0.8 grams of protein per kilogram of body weight). That's roughly 60 grams for men and 50 grams for women per day, based on body weights of 165 pounds (75 kilograms) for men and 143 pounds (65 kilograms) for women. In most rich countries, the average adult gets far more, Amati said. Protein deficiencies are mostly seen in malnourished people on subsistence diet in poorer countries, she said. Bridget Benelam, a nutritionist with the British Nutrition Foundation, said it was important to get protein from different foods, like dairy, fish, beans, nuts, vegetables and meat. She said studies suggest vegetarians and vegans have lower protein intake than meat and fish eaters, but that their average protein levels are still OK. Having some protein at every meal is also a likely a good idea. 'It appears to be better for preserving muscle function if you have some protein throughout the day, rather than just having it all in one meal,' Benelam said. Protein can be found in a huge range of food Plant-based sources of protein include foods such as beans, lentils, peas, nuts, seeds, tofu, tempeh and meat substitutes. Fish, meat, poultry, eggs and dairy foods such as milk and yogurt are also good sources of protein. Amati said that proteins from animal-based sources may be easier for the body to break down compared to plant-based proteins, which tend to have more fiber. 'If you eat a piece of beef, you're getting protein and things like zinc and iron, but you're also getting more saturated fat,' she said. In comparison, Amati said eating protein-rich foods like chickpeas or beans also provides the body with fiber, something that's lacking in most of our diets. You probably don't need to buy products with added protein 'Unless you have a specific health issue that requires you to have more protein, most people in countries like the U.S. and the U.K. do not need more,' said Benelam of the British Nutrition Foundation. Amati, of Imperial College London, said people should scrutinize the ingredient list of protein-enriched products to make sure they aren't loaded with sugar and fat. For people trying to build more muscle, she recommended a more direct solution: exercise. 'If you're worried about your body composition and muscle strength, you have to lift (heavier) weights and give your body a challenge,' Amati said. 'Eating a protein bar is not going to help.' The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Maria Cheng, The Associated Press
Globe and Mail
a day ago
- Globe and Mail
Ovarian Cancer Market Forecast to 2034: Advancing Treatment Frontiers and Epidemiological Shifts
Ovarian cancer remains a significant global health challenge, often diagnosed at an advanced stage due to non-specific symptoms and a lack of effective early screening. It encompasses a spectrum of histological subtypes, including high-grade serous (HGSOC), low-grade serous (LGSOC), and epithelial tumors, each with unique biological and clinical features. High recurrence rates and poor long-term survival continue to drive the urgent need for improved treatment options and earlier detection. DelveInsight's latest report, ' Ovarian Cancer – Market Insight, Epidemiology, and Market Forecast – 2034,' provides a comprehensive overview of the disease's burden across the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan. It offers in-depth segmentation by subtype, stage, age group, and biomarker status, alongside historical and projected epidemiological trends. The analysis highlights rising incidence rates, shifting subtype proportions—particularly serous carcinomas—and the evolving landscape of diagnostic and therapeutic innovation. The ovarian cancer market has transformed in recent years, driven by the expanding use of PARP inhibitors, antiangiogenic agents, and emerging targeted therapies. These options have shifted the treatment paradigm, particularly for BRCA-mutated, HRD-positive, and platinum-sensitive disease. Nonetheless, persistent issues such as chemoresistance, limited options in late-line settings, and variability in biomarker testing are hindering further progress. Looking ahead, the market is anticipated to grow steadily through 2034, propelled by innovations in epigenetic modulators, antibody-drug conjugates (ADCs), immune-oncology combinations, and advanced diagnostics like liquid biopsies. Enhanced biomarker testing and personalized treatment strategies will support optimized patient care. DelveInsight's full report explores pipeline highlights, market drivers and barriers, and strategic recommendations for stakeholders aiming to transform the outlook for ovarian cancer patients. Request a sample and uncover the latest breakthroughs shaping the Ovarian Cancer market landscape and future outlook Some of the key insights of the Ovarian Cancer Market Report: • In 2024, the ovarian cancer market in the 7MM was valued at USD 2.7 billion. • Market size is expected to grow with the launch of new ovarian cancer therapies. • The U.S. held the largest share, reaching USD 1.92 billion in 2024. • Total incident ovarian cancer cases in the 7MM were 61K in 2024. • The U.S. reported the highest number of high and low-grade serous ovarian cancer cases. • There were approximately 37.6K serous ovarian cancer cases in the 7MM in 2024. • In January 2025, IPS HEART received Orphan Drug Designation (ODD) from the FDA for GIVI-MPCs, recognizing their potential to create new muscle with full-length dystrophin in Becker Muscular Dystrophy (BMD). The therapy has shown promising results in generating human muscle with full-length dystrophin in dystrophic pigs, young and aged Duchenne Muscular Dystrophy (DMD) mice, and an Ovarian Cancer mouse model. • In April 2025, Biocon Biologics received FDA approval for JOBEVNE (bevacizumab-nwgd), a biosimilar to Avastin®, for intravenous use. JOBEVNE is approved for multiple cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer, and ovarian, fallopian tube, or primary peritoneal cancer. • In February 2025, the FDA granted fast-track designation to CUSP06, a CDH6-directed antibody-drug conjugate (ADC), for the treatment of patients with platinum-resistant ovarian cancer. • Emerging therapies for ovarian cancer include Avutometinib + defactinib, Relacorilant, IMFINZI, Rinatabart sesutecan, Olvimulogene nanivacirepvec, Nemvaleukin alfa, Catequentinib, Raludotatug deruxtecan, Luveltamab Tazevibulin, Sacituzumab tirumotecan, Azenosertib (ZN-c3) + Niraparib, TORL-1-23, and others. • Key companies involved in the treatment of ovarian cancer include Genmab, AstraZeneca, On Target Laboratories, Chipscreen Biosciences, Aravive, Inc., Allarity Therapeutics, Merck KGaA, GlaxoSmithKline, Aprea Therapeutics, Verastem, Inc., Ellipses Pharma, Impact Therapeutics, Inc., BeiGene, Apexigen, Novartis Oncology, VBL Therapeutics, Cristal Therapeutics, Bayer, Regeneron Pharmaceuticals, DCPrime BV, AIM ImmunoTech Inc., Pharmicell Co., Ltd., Shattuck Labs, Inc., Laekna Limited, Celsion, and others. Curious to see the graphical version of these numbers? The ovarian cancer infographic is ready for you. Check it out here! Ovarian Cancer Overview Ovarian cancer is a complex and often late-diagnosed malignancy arising from the epithelial cells, stromal cells, or germ cells of the ovary. Among these, epithelial ovarian cancer is the most prevalent, accounting for over 90% of malignant ovarian tumors. Due to its subtle early symptoms and lack of reliable screening methods, the disease is frequently diagnosed at advanced stages, contributing to its high mortality rate among gynecological cancers. The most common and aggressive subtype is High-Grade Serous Ovarian Cancer (HGSOC), which often presents with widespread peritoneal metastases. In contrast, Low-Grade Serous Ovarian Cancer (LGSOC) tends to follow a more indolent course but shows resistance to standard chemotherapy, highlighting a critical unmet need for targeted therapies. Genetic mutations such as BRCA1/2 and alterations in the MAPK pathway (BRAF/KRAS/NRAS/NF1) and homologous recombination deficiency (HRD) status play a pivotal role in disease stratification and therapy selection. Over the past decade, the ovarian cancer treatment landscape has evolved with the introduction of PARP inhibitors, anti-angiogenic agents, and targeted therapies that have significantly improved outcomes in biomarker-driven subpopulations. Despite these advancements, resistance development, limited options for certain subtypes like LGSOC, and high relapse rates continue to challenge long-term disease control. As research progresses, efforts are focused on improving early diagnosis, personalizing treatment based on molecular profiling, and expanding therapeutic options through clinical trials and novel drug development. Get a free sample for the Ovarian Cancer market forecast, size & share analysis report: Ovarian Cancer Epidemiology The epidemiology section offers an overview of historical, current, and projected trends in the seven major countries (7MM) from 2020 to 2034. It helps identify the factors influencing these trends by examining various studies and perspectives from key opinion leaders. Additionally, the section provides an in-depth analysis of the diagnosed patient population and future trends. Ovarian Cancer Epidemiology Segmentation: The Ovarian Cancer market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM, segmented into: • Total incident cases of Ovarian Cancer • Age-specific cases of Ovarian Cancer • Type-Specific Cases of Ovarian Cancer • Stage-specific Cases of high and Low-Grade Serous Ovarian Cancer • Biomarker-specific Cases of high and Low-Grade Serous Ovarian Cancer Ovarian Cancer Drugs Uptake and Pipeline Development Activities The Drug Uptake section offers a detailed analysis of the adoption trends of newly launched and upcoming therapies for Ovarian Cancer throughout the study period. It evaluates patient adoption rates, market penetration, and the commercial performance of each therapy, providing a clear understanding of the factors driving or hindering the market acceptance of these treatments. The Therapeutics Assessment further highlights the Ovarian Cancer drugs, demonstrating the most rapid uptake. It examines the underlying drivers contributing to their swift adoption and compares the market share of these therapies to identify those gaining significant traction. Additionally, the report provides an in-depth overview of the current therapeutic pipeline for Ovarian Cancer, covering investigational drugs at various stages of development. It profiles the key pharmaceutical and biotech companies actively involved in advancing targeted treatments and presents the latest updates on partnerships, mergers and acquisitions, licensing deals, and other strategic developments shaping the future of Ovarian Cancer therapeutics. Ovarian Cancer Market Outlook The ovarian cancer treatment landscape is undergoing a significant transformation, with the integration of targeted therapies, personalized medicine, and ongoing clinical research aimed at improving long-term outcomes. High-grade serous ovarian cancer (HGSOC), the most prevalent subtype, continues to be treated with a combination of surgery and platinum-based chemotherapy. However, the emergence of maintenance therapies—especially PARP inhibitors—has reshaped post-treatment strategies for patients with BRCA or HRD mutations, helping reduce recurrence rates and extend progression-free survival. The future of ovarian cancer care is increasingly personalized, with clinical trials exploring novel options like immunotherapy, vaccine-based approaches, and radiation strategies for advanced or recurrent disease. These innovations reflect a broader trend toward therapies tailored to molecular profiles and disease stage, moving away from one-size-fits-all treatment. However, disparities in access to care remain a major challenge. Socioeconomic, racial, and geographic barriers often limit timely diagnosis and appropriate treatment, particularly in underserved populations. As awareness of BRCA testing and biomarker-driven treatment grows, expanding access to genetic screening and oncology expertise will be crucial. The ovarian cancer market is expected to expand steadily through 2034, driven by rising disease burden, evolving therapeutic options, and a growing emphasis on precision medicine. Addressing current gaps in care delivery, especially among high-risk and underserved groups, will be essential to unlocking the full potential of these medical advancements. Ovarian Cancer Market Drivers • The introduction of PARP inhibitors (e.g., olaparib, niraparib) and other targeted agents based on BRCA and HRD status has revolutionized ovarian cancer treatment, improving survival and reducing recurrence in select patient groups. • Increasing adoption of genetic and molecular testing for BRCA mutations, HRD status, and other biomarkers is enabling personalized treatment strategies, driving demand for advanced therapeutic options. Ovarian Cancer Market Barriers • The absence of reliable early screening methods and vague initial symptoms often lead to diagnosis at advanced stages, limiting curative treatment options and affecting patient outcomes. • Limited access to specialized oncology care, especially in rural and low-income regions, along with underutilization of genetic testing among minority populations, continues to hinder equitable treatment and diagnosis. Scope of the Ovarian Cancer Market Report • Study Period: 2020–2034 • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]. • Key Ovarian Cancer Companies: Genmab, AstraZeneca, On Target Laboratories, Chipscreen Biosciences, Aravive, Inc., Allarity Therapeutics, Merck KGaA, GlaxoSmithKline, Aprea Therapeutics, Verastem, Inc., Ellipses Pharma, Impact Therapeutics, Inc., BeiGene, Apexigen, Novartis Oncology, VBL Therapeutics, Cristal Therapeutics, Bayer, Regeneron Pharmaceuticals, DCPrime BV, AIM ImmunoTech Inc., Pharmicell Co., Ltd., Shattuck Labs, Inc., Laekna Limited, Celsion, and others. • Key Ovarian Cancer Therapies: Avutometinib + defactinib, Relacorilant, IMFINZI, Rinatabart sesutecan, Olvimulogene nanivacirepvec, Nemvaleukin alfa, Catequentinib, Raludotatug deruxtecan, Luveltamab Tazevibulin, Sacituzumab tirumotecan, Azenosertib (ZN-c3) + Niraparib, TORL-1-23, and others. • Ovarian Cancer Therapeutic Assessment: Ovarian Cancer currently marketed, and Ovarian Cancer emerging therapies. • Ovarian Cancer Market Dynamics: Ovarian Cancer market drivers and Ovarian Cancer market barriers. • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies. • Ovarian Cancer Unmet Needs, KOL's views, Analyst's views, Ovarian Cancer Market Access and Reimbursement. Table of Contents 1. Ovarian Cancer Market Report Introduction 2. Executive Summary for Ovarian Cancer 3. SWOT analysis of Ovarian Cancer 4. Ovarian Cancer Patient Share (%) Overview at a Glance 5. Ovarian Cancer Market Overview at a Glance 6. Ovarian Cancer Disease Background and Overview 7. Ovarian Cancer Epidemiology and Patient Population 8. Country-Specific Patient Population of Ovarian Cancer 9. Ovarian Cancer Current Treatment and Medical Practices 10. Ovarian Cancer Unmet Needs 11. Ovarian Cancer Emerging Therapies 12. Ovarian Cancer Market Outlook 13. Country-Wise Ovarian Cancer Market Analysis (2020–2034) 14. Ovarian Cancer Market Access and Reimbursement of Therapies 15. Ovarian Cancer Market Drivers 16. Ovarian Cancer Market Barriers 17. Ovarian Cancer Appendix 18. Ovarian Cancer Report Methodology 19. DelveInsight Capabilities 20. Disclaimer 21. About DelveInsight About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform, PharmDelve. Media Contact Company Name: DelveInsight Contact Person: Jatin Vimal Email: Send Email Phone: +14699457679 Address: 304 S. Jones Blvd #2432 City: Las Vegas State: Nevada Country: United States Website:
